Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy
Saved in:
Published in | Brain (London, England : 1878) Vol. 136; no. Pt 2; p. e230 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Oxford University Press
01.02.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Author | Metz, G Meier, T Reznicek, L Nwali, N Coppard, N Gallenmüller, C Rouleau, J Büchner, B von Livonius, B Yu-Wai-Man, P Chinnery, P F Griffiths, P G Klopstock, T Bailie, M |
---|---|
AuthorAffiliation | 2 Santhera Pharmaceuticals, 4410 Liestal, Switzerland 6 Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec H2L 4M1, Canada 1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, 80336 Munich, Germany 5 Department of Ophthalmology, Ludwig-Maximilians-University, Munich 80336, Germany 3 Departments of Neurology and Ophthalmology, Newcastle upon Tyne Foundation Hospital NHS Foundation Trust, NE1 4LP UK 4 Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK |
AuthorAffiliation_xml | – name: 3 Departments of Neurology and Ophthalmology, Newcastle upon Tyne Foundation Hospital NHS Foundation Trust, NE1 4LP UK – name: 5 Department of Ophthalmology, Ludwig-Maximilians-University, Munich 80336, Germany – name: 2 Santhera Pharmaceuticals, 4410 Liestal, Switzerland – name: 4 Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK – name: 1 Department of Neurology, Friedrich-Baur-Institute, Ludwig-Maximilians-University, 80336 Munich, Germany – name: 6 Department of Ophthalmology, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Quebec H2L 4M1, Canada |
Author_xml | – sequence: 1 givenname: T surname: Klopstock fullname: Klopstock, T – sequence: 2 givenname: G surname: Metz fullname: Metz, G – sequence: 3 givenname: P surname: Yu-Wai-Man fullname: Yu-Wai-Man, P – sequence: 4 givenname: B surname: Büchner fullname: Büchner, B – sequence: 5 givenname: C surname: Gallenmüller fullname: Gallenmüller, C – sequence: 6 givenname: M surname: Bailie fullname: Bailie, M – sequence: 7 givenname: N surname: Nwali fullname: Nwali, N – sequence: 8 givenname: P G surname: Griffiths fullname: Griffiths, P G – sequence: 9 givenname: B surname: von Livonius fullname: von Livonius, B – sequence: 10 givenname: L surname: Reznicek fullname: Reznicek, L – sequence: 11 givenname: J surname: Rouleau fullname: Rouleau, J – sequence: 12 givenname: N surname: Coppard fullname: Coppard, N – sequence: 13 givenname: T surname: Meier fullname: Meier, T – sequence: 14 givenname: P F surname: Chinnery fullname: Chinnery, P F |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/23388409$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkMtLAzEQxoNU7ENvniU3L67Nax-5CFJ8QUEPBY8hm524kTZbklTpf-_WatHTDDPffPPxG6OB7zwgdE7JNSWST-ugnZ_qz8hKeYRGVBQkYzQvBmhECCmySuZkiMYxvhNCBWfFCRoyzqtKEDlCry8QoosJvAHcWZxawCmATivwCYO1YNJu7hqoYfcZO4_nfR8uI24hQOOSDlvcrZMz2MMmdGud2u0pOrZ6GeHsp07Q4v5uMXvM5s8PT7PbeWZEWaTM1ASEyKsi50LUjdFWWqYrA0A1q8CWIGhdNUwY4CSXVuaNpJTownBNbMMn6GZvu97UK2hMHzropVoHt-pTqU479X_jXaveug_F85JJTnuDq72BCV2MAezhlhK146u--ao9315-8fffQfwLlH8B0oF9hg |
CitedBy_id | crossref_primary_10_1016_j_ebiom_2021_103244 crossref_primary_10_29014_ns_2018_31 crossref_primary_10_1016_j_neurol_2014_03_009 crossref_primary_10_1016_j_ymgme_2020_06_011 crossref_primary_10_1111_jfbc_13230 crossref_primary_10_1038_nrneurol_2014_228 crossref_primary_10_1080_02713683_2020_1736307 crossref_primary_10_3390_ijms241612580 crossref_primary_10_1007_s10384_020_00789_2 crossref_primary_10_3390_life13102000 crossref_primary_10_1177_2326409817752960 crossref_primary_10_1159_000381726 crossref_primary_10_1038_eye_2014_37 crossref_primary_10_1016_j_ajo_2022_11_004 crossref_primary_10_1146_annurev_vision_102016_061422 crossref_primary_10_1016_j_omtn_2022_10_012 crossref_primary_10_1016_j_spen_2017_06_001 crossref_primary_10_1016_j_pharmthera_2016_06_004 crossref_primary_10_1177_2326409817731112 crossref_primary_10_1212_WNL_0000000000013084 crossref_primary_10_3390_jcm9041112 crossref_primary_10_1016_j_neurot_2023_e00311 crossref_primary_10_1080_01658107_2022_2032761 crossref_primary_10_1016_j_freeradbiomed_2015_05_041 crossref_primary_10_1097_APO_0000000000000220 crossref_primary_10_1007_s40265_020_01428_3 crossref_primary_10_1016_j_crvi_2013_11_011 crossref_primary_10_1021_acs_bioconjchem_0c00470 crossref_primary_10_3390_antiox12071464 crossref_primary_10_3390_medicina57030202 crossref_primary_10_1517_21678707_2015_1098531 crossref_primary_10_4103_tjo_tjo_68_20 crossref_primary_10_3390_cells12152013 crossref_primary_10_3390_pharmaceutics12111083 crossref_primary_10_1016_S1474_4422_13_70158_3 crossref_primary_10_1093_hmg_ddv396 crossref_primary_10_1097_ICU_0000000000000891 crossref_primary_10_1007_s12325_018_0776_z crossref_primary_10_1155_2015_835986 crossref_primary_10_1016_j_oftal_2016_06_005 crossref_primary_10_1016_j_preteyeres_2024_101264 crossref_primary_10_3390_ph13080184 crossref_primary_10_1097_WNO_0000000000000570 crossref_primary_10_1016_j_ijpharm_2014_12_044 crossref_primary_10_1097_ICU_0000000000000410 crossref_primary_10_1097_OPX_0000000000000991 crossref_primary_10_1016_j_oftale_2016_09_008 crossref_primary_10_1038_nrdp_2016_80 crossref_primary_10_1007_s11910_022_01246_y crossref_primary_10_1111_ene_15847 crossref_primary_10_5692_clinicalneurol_cn_001924 crossref_primary_10_1080_10837450_2016_1231811 crossref_primary_10_1016_j_ymgme_2020_10_002 crossref_primary_10_1080_01658107_2016_1213860 crossref_primary_10_1097_IIO_0000000000000364 crossref_primary_10_1002_glia_22670 crossref_primary_10_1016_j_mito_2017_01_004 crossref_primary_10_1016_j_omtn_2021_08_015 crossref_primary_10_1016_j_addr_2020_09_010 crossref_primary_10_1016_j_ebiom_2017_02_013 crossref_primary_10_1177_0883073814538509 crossref_primary_10_1007_s00401_016_1625_2 crossref_primary_10_3390_genes12010112 crossref_primary_10_1038_s41434_022_00333_6 crossref_primary_10_1080_13816810_2020_1755988 crossref_primary_10_3390_ph13020029 crossref_primary_10_1007_s00417_020_04993_1 crossref_primary_10_1080_13102818_2023_2255073 crossref_primary_10_1126_science_1250256 crossref_primary_10_1016_j_mito_2016_11_006 crossref_primary_10_1177_0883073813492895 crossref_primary_10_4103_ijo_IJO_358_17 crossref_primary_10_1056_NEJMcpc1900597 crossref_primary_10_1016_S1474_4422_22_00174_0 crossref_primary_10_33549_physiolres_934529 crossref_primary_10_1016_j_jfo_2013_05_007 crossref_primary_10_1016_j_praneu_2016_01_010 crossref_primary_10_1097_WNO_0000000000000830 crossref_primary_10_3390_cells12010020 crossref_primary_10_1002_adma_202103307 crossref_primary_10_1517_21678707_2016_1117972 crossref_primary_10_1167_tvst_10_8_4 crossref_primary_10_3390_pharmaceutics15020322 crossref_primary_10_1016_j_ymgme_2017_09_009 crossref_primary_10_1212_01_wnl_0000437308_22603_43 crossref_primary_10_1016_j_phrs_2018_09_024 crossref_primary_10_1007_s40265_016_0574_3 crossref_primary_10_1016_j_mito_2023_01_006 crossref_primary_10_3390_antiox11112293 crossref_primary_10_3389_fneur_2021_651639 crossref_primary_10_1093_brain_aww058 crossref_primary_10_1007_s00347_019_0864_8 crossref_primary_10_1136_bjophthalmol_2021_320580 crossref_primary_10_1146_annurev_vision_082114_035651 crossref_primary_10_1111_exd_12484 crossref_primary_10_1016_S0181_5512_22_00447_8 crossref_primary_10_1016_j_clnesp_2022_06_016 crossref_primary_10_3390_antiox10121948 crossref_primary_10_1016_j_cell_2020_02_051 crossref_primary_10_1042_EBC20170114 crossref_primary_10_17925_USOR_2023_17_1_21 crossref_primary_10_2174_1570159X15666171109125643 crossref_primary_10_3390_ijms22094793 crossref_primary_10_1186_s12886_017_0583_3 crossref_primary_10_1093_brain_aww085 crossref_primary_10_1097_ICU_0000000000000212 crossref_primary_10_1097_WCO_0000000000000646 crossref_primary_10_1093_bmb_ldv046 crossref_primary_10_3390_jcto2030006 crossref_primary_10_1016_j_ymgme_2014_09_013 crossref_primary_10_3109_08820538_2015_1115251 crossref_primary_10_1016_j_cbpc_2022_109509 crossref_primary_10_1007_s11910_020_01032_8 crossref_primary_10_1002_jmd2_12068 crossref_primary_10_1089_ars_2014_5952 crossref_primary_10_1007_s10384_024_01077_z crossref_primary_10_1016_j_jfo_2018_06_010 crossref_primary_10_1038_nrneph_2018_9 crossref_primary_10_1080_1028415X_2017_1368170 crossref_primary_10_3390_antiox10020236 crossref_primary_10_3389_fopht_2022_1077395 |
Cites_doi | 10.1016/S0022-510X(96)00311-5 10.4321/S0365-66912007000600012 10.1136/jnnp.71.6.813 10.1093/brain/awr180 10.1016/S0042-6989(97)00444-6 10.1016/S0022-510X(98)00239-1 10.1016/0140-6736(92)91442-B 10.1371/journal.pone.0017963 10.1093/brain/awr170 10.1097/WNO.0b013e318241da45 10.1097/00041327-200020030-00006 |
ContentType | Journal Article |
Copyright | The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. 2013 |
Copyright_xml | – notice: The Author (2013). Published by Oxford University Press on behalf of the Guarantors of Brain. 2013 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1093/brain/aws279 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1460-2156 |
EndPage | e230 |
ExternalDocumentID | 10_1093_brain_aws279 23388409 |
Genre | Letter Randomized Controlled Trial Research Support, Non-U.S. Gov't |
GrantInformation_xml | – fundername: Wellcome Trust grantid: 101876 – fundername: Medical Research Council grantid: G0701386 – fundername: Medical Research Council grantid: MR/K000608/1 – fundername: Wellcome Trust grantid: 096919 – fundername: Medical Research Council grantid: G1002570 |
GroupedDBID | --- -E4 -~X .2P .55 .GJ .I3 .XZ .ZR 0R~ 1CY 1TH 23N 2WC 354 3O- 4.4 41~ 482 48X 53G 5GY 5RE 5VS 5WA 5WD 6.Y 6PF 70D AABZA AACZT AAGKA AAIMJ AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAVLN AAWDT AAWTL AAYJJ ABEUO ABIVO ABIXL ABJNI ABKDP ABLJU ABMNT ABNHQ ABNKS ABPTD ABQLI ABQNK ABQTQ ABSAR ABSMQ ABWST ABXVV ABZBJ ACBNA ACFRR ACGFS ACIWK ACPQN ACPRK ACUFI ACUTJ ACUTO ACYHN ACZBC ADBBV ADEYI ADEZT ADGKP ADGZP ADHKW ADHZD ADIPN ADJQC ADOCK ADQBN ADRIX ADRTK ADVEK ADYVW ADZXQ AEGPL AEHUL AEJOX AEKPW AEKSI AELWJ AEMDU AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFGWE AFIYH AFOFC AFSHK AFXAL AFXEN AFYAG AGINJ AGKEF AGKRT AGMDO AGQXC AGSYK AGUTN AHMBA AHXPO AI. AIJHB AJEEA AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ANFBD APIBT APJGH APWMN AQDSO AQKUS ARIXL ASAOO ASPBG ATDFG ATGXG ATTQO AVNTJ AVWKF AXUDD AYOIW AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BQDIO BR6 BSWAC BTRTY BVRKM BZKNY C1A C45 CAG CDBKE CGR COF CS3 CUY CVF CXTWN CZ4 DAKXR DFGAJ DIK DILTD DU5 D~K E3Z EBS ECM EE~ EIF EIHJH EJD ELUNK EMOBN ENERS F20 F5P F9B FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK G8K GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 J5H JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z M49 MBLQV MBTAY MHKGH ML0 MVM N4W N9A NGC NLBLG NOMLY NOYVH NPM NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBOKY OCZFY ODMLO OHH OHT OJQWA OJZSN OK1 OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y QBD R44 RD5 RIG RNI ROL ROX ROZ RUSNO RW1 RXO RZF RZO TCN TCURE TEORI TJX TLC TMA TR2 VH1 VVN W8F WH7 WOQ X7H X7M XJT XOL YAYTL YKOAZ YQJ YSK YXANX ZCG ZGI ZKB ZKX ZXP ~91 AASNB AAYXX CITATION KC5 5PM |
ID | FETCH-LOGICAL-c476t-cb0e445865344bdcaf9f2a8cee1a28ef7e41b8d24ce3059f95d9110a6c3a0fd3 |
ISSN | 0006-8950 |
IngestDate | Tue Sep 17 20:51:42 EDT 2024 Thu Sep 26 15:45:04 EDT 2024 Wed Oct 16 00:44:10 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Pt 2 |
Language | English |
License | This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c476t-cb0e445865344bdcaf9f2a8cee1a28ef7e41b8d24ce3059f95d9110a6c3a0fd3 |
OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC3572931 |
PMID | 23388409 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3572931 crossref_primary_10_1093_brain_aws279 pubmed_primary_23388409 |
PublicationCentury | 2000 |
PublicationDate | 2013-02-01 |
PublicationDateYYYYMMDD | 2013-02-01 |
PublicationDate_xml | – month: 02 year: 2013 text: 2013-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Brain (London, England : 1878) |
PublicationTitleAlternate | Brain |
PublicationYear | 2013 |
Publisher | Oxford University Press |
Publisher_xml | – name: Oxford University Press |
References | Klopstock ( key 20170405101931_aws279-B8) 2011; 134 Cortelli ( key 20170405101931_aws279-B5) 1997; 148 Carelli ( key 20170405101931_aws279-B3) 2011; 134 Sabet-Peyman ( key 20170405101931_aws279-B11) 2012; 32 Barnils ( key 20170405101931_aws279-B1) 2007; 82 Mashima ( key 20170405101931_aws279-B9) 1992; 340 Carelli ( key 20170405101931_aws279-B2) 1998; 160 Carelli ( key 20170405101931_aws279-B4) 2001; 71 Mashima ( key 20170405101931_aws279-B10) 2000; 20 Haefeli ( key 20170405101931_aws279-B6) 2011; 6 Howell ( key 20170405101931_aws279-B7) 1998; 38 |
References_xml | – volume: 148 start-page: 25 year: 1997 ident: key 20170405101931_aws279-B5 article-title: Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study publication-title: J Neurol Sci doi: 10.1016/S0022-510X(96)00311-5 contributor: fullname: Cortelli – volume: 82 start-page: 377 year: 2007 ident: key 20170405101931_aws279-B1 article-title: Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy publication-title: Arch Soc Esp Oftalmol doi: 10.4321/S0365-66912007000600012 contributor: fullname: Barnils – volume: 71 start-page: 813 year: 2001 ident: key 20170405101931_aws279-B4 article-title: Leber's hereditary optic neuropathy (LHON/11778) with myoclonus: report of two cases publication-title: J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp.71.6.813 contributor: fullname: Carelli – volume: 134 start-page: e188 year: 2011 ident: key 20170405101931_aws279-B3 article-title: Idebenone treatment in Leber's hereditary optic neuropathy publication-title: Brain doi: 10.1093/brain/awr180 contributor: fullname: Carelli – volume: 38 start-page: 1495 year: 1998 ident: key 20170405101931_aws279-B7 article-title: Leber hereditary optic neuropathy: respiratory chain dysfunction and degeneration of the optic nerve publication-title: Vision Res doi: 10.1016/S0042-6989(97)00444-6 contributor: fullname: Howell – volume: 160 start-page: 183 year: 1998 ident: key 20170405101931_aws279-B2 article-title: Leber's hereditary optic neuropathy (LHON) with 14484/ND6 mutation in a North African patient publication-title: J Neurol Sci doi: 10.1016/S0022-510X(98)00239-1 contributor: fullname: Carelli – volume: 340 start-page: 368 year: 1992 ident: key 20170405101931_aws279-B9 article-title: Remission of Leber's hereditary optic neuropathy with idebenone publication-title: Lancet doi: 10.1016/0140-6736(92)91442-B contributor: fullname: Mashima – volume: 6 start-page: e17963 year: 2011 ident: key 20170405101931_aws279-B6 article-title: NQO1-dependent redox cycling of idebenone: effects on cellular redox potential and energy levels publication-title: PLoS One doi: 10.1371/journal.pone.0017963 contributor: fullname: Haefeli – volume: 134 start-page: 2677 year: 2011 ident: key 20170405101931_aws279-B8 article-title: A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy publication-title: Brain doi: 10.1093/brain/awr170 contributor: fullname: Klopstock – volume: 32 start-page: 54 year: 2012 ident: key 20170405101931_aws279-B11 article-title: Is leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case publication-title: J Neuroophthalmol doi: 10.1097/WNO.0b013e318241da45 contributor: fullname: Sabet-Peyman – volume: 20 start-page: 166 year: 2000 ident: key 20170405101931_aws279-B10 article-title: Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy? publication-title: J Neuroophthalmol doi: 10.1097/00041327-200020030-00006 contributor: fullname: Mashima |
SSID | ssj0014326 |
Score | 2.5109413 |
SourceID | pubmedcentral crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | e230 |
SubjectTerms | Adolescent Adult Aged Cohort Studies Double-Blind Method Female Follow-Up Studies Humans Letters to the Editor Male Middle Aged Optic Atrophy, Hereditary, Leber - drug therapy Optic Atrophy, Hereditary, Leber - epidemiology Optic Atrophy, Hereditary, Leber - physiopathology Time Factors Treatment Outcome Ubiquinone - analogs & derivatives Ubiquinone - pharmacology Ubiquinone - therapeutic use Visual Acuity - drug effects Visual Acuity - physiology Young Adult |
Title | Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy |
URI | https://www.ncbi.nlm.nih.gov/pubmed/23388409 https://pubmed.ncbi.nlm.nih.gov/PMC3572931 |
Volume | 136 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbhMxELZCKyEuqJSfhgLyAU7I6Wb9s_aRVLQVEMQhiPQUeb1eNVKVRMlGSJx4CqS-Xp-Esb1xdiGHwsXaOOtk1_N5PB6Pv0HotWYWFGOWEGNKn8JMwJCygqTK2rxgkmufM3L4WVx8ZR_GfNzp_GpELa2rvGd-7DxX8j9ShTqQqzsl-w-SjT8KFXAN8oUSJAzlnWTswtedmNzgrPf6t4HjIVLDU0IU0IewzPf8IJ_gerkJcVArsBSXMH9VLnhuvnDsrZ7h0iUqbm_4ulQSO_N_BKeCzGTDqfDxer4AqzKo2lEvStX67LFvz2PN5Zp801MyDG7YL7F-4DbwB6dmcx5n0Gu6J1yqiBjqsVG5gkgV2GV7NmhZJhICtoZoqeFAhFLjLW0oVZvWWze29fEv5R-IsfKld6mc6e-rNOSpabNs_zH7xZjEsBtPJ779JLS-h_ahpE5zno9j6BCYmD6NX3y1-kAFtD7xrU9C65apE-2bduxtw5gZHaCH9SoEvwuQeoQ6dnaI7g_rOIvH6LKBLDwvMSALR2ThgCxXH5GFpzPskXX782aFt5jCHlN4i6knaHT2fnR6QeokHMSwTFTE5IlljEvBKWN5YXSpylRLsK36MIxtmVnWz2WRMgODnqtS8QLmz0QLQ3VSFvQp2nOPcYSw7qcmUxzsSaWZ5m6pYhNtrFFFaTMtu-jNprsmi0C1MtkllC56Frow3pVSKp2joouyVufGGxyHevub2fTKc6lTDqtL2n9-x_8-Rg-2IH-B9qrl2r4Eq7TKX3mI_AYeNJC8 |
link.rule.ids | 230,315,783,787,888,27936,27937 |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Persistence+of+the+treatment+effect+of+idebenone+in+Leber%E2%80%99s+hereditary+optic+neuropathy&rft.jtitle=Brain+%28London%2C+England+%3A+1878%29&rft.au=Klopstock%2C+T.&rft.au=Metz%2C+G.&rft.au=Yu-Wai-Man%2C+P.&rft.au=B%C3%BCchner%2C+B.&rft.date=2013-02-01&rft.issn=0006-8950&rft.eissn=1460-2156&rft.volume=136&rft.issue=2&rft.spage=e230&rft.epage=e230&rft_id=info:doi/10.1093%2Fbrain%2Faws279&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_brain_aws279 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0006-8950&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0006-8950&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0006-8950&client=summon |